The Blood Consent Working Group of the Transfusion Utilization and Safety Interdisciplinary Committee – Steering Committee (TUSIC-SC) is pleased to announce the release of a new provincial Consent/Refusal of Blood Transfusions form (SHA 0723) for use across the Saskatchewan Health Authority, effective October 27, 2026.

Informed consent must be obtained by the Most Responsible Practitioner (MRP) before administration of blood components and/or blood products, as detailed in SHA Clinical Standard Administration of Blood Components and Blood Products (CS-CS-0018). The consent is valid for:

• the duration of a single hospital admission for the indication documented; or
• a maximum of 12 months during the course of treatment for which consent was obtained, as long as the patient’s condition and indication for transfusion have not changed

o Examples: Humate P for treatment or prevention of bleeding due to congenital von Willebrand disease; IVIG monthly for IgG replacement in the setting of primary immune deficiency.